Citadel Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Sell |
492,132
-859,209
| -64% | -$9.68M | ﹤0.01% | 1817 |
|
|
2025
Q1 | $13.6M | Sell |
1,351,341
-453,438
| -25% | -$4.58M | ﹤0.01% | 1083 |
|
|
2024
Q4 | $21.4M | Sell |
1,804,779
-4,123,404
| -70% | -$48.8M | ﹤0.01% | 906 |
|
|
2024
Q3 | $68.4M | Buy |
5,928,183
+4,004,146
| +208% | +$46.2M | 0.01% | 365 |
|
|
2024
Q2 | $20.3M | Sell |
1,924,037
-1,215,542
| -39% | -$12.8M | ﹤0.01% | 867 |
|
|
2024
Q1 | $33.1M | Sell |
3,139,579
-342,124
| -10% | -$3.61M | 0.01% | 644 |
|
|
2023
Q4 | $39.1M | Buy |
3,481,703
+3,355,500
| +2,659% | +$37.7M | 0.01% | 560 |
|
|
2023
Q3 | $1.47M | Buy |
126,203
+101,024
| +401% | +$1.18M | ﹤0.01% | 2677 |
|
|
2023
Q2 | $254K | Sell |
25,179
-1,378,661
| -98% | -$13.9M | ﹤0.01% | 4247 |
|
|
2023
Q1 | $10.4M | Buy |
1,403,840
+539,869
| +62% | +$3.98M | ﹤0.01% | 1293 |
|
|
2022
Q4 | $6.9M | Sell |
863,971
-570,054
| -40% | -$4.55M | ﹤0.01% | 1538 |
|
|
2022
Q3 | $4.62M | Buy |
1,434,025
+1,246,676
| +665% | +$4.01M | ﹤0.01% | 1928 |
|
|
2022
Q2 | $762K | Buy |
+187,349
| New | +$762K | ﹤0.01% | 3700 |
|